DK1556488T3 - Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme - Google Patents
Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdommeInfo
- Publication number
- DK1556488T3 DK1556488T3 DK03758057T DK03758057T DK1556488T3 DK 1556488 T3 DK1556488 T3 DK 1556488T3 DK 03758057 T DK03758057 T DK 03758057T DK 03758057 T DK03758057 T DK 03758057T DK 1556488 T3 DK1556488 T3 DK 1556488T3
- Authority
- DK
- Denmark
- Prior art keywords
- diseases
- chondroosteomodulin
- tig2
- obesity
- diagnosis
- Prior art date
Links
- 208000020084 Bone disease Diseases 0.000 title 1
- 101001132652 Homo sapiens Retinoic acid receptor responder protein 2 Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 title 1
- 102100033914 Retinoic acid receptor responder protein 2 Human genes 0.000 title 1
- 208000015100 cartilage disease Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 208000017520 skin disease Diseases 0.000 title 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10251205 | 2002-10-31 | ||
| PCT/EP2003/011799 WO2004039978A2 (de) | 2002-10-31 | 2003-10-24 | Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1556488T3 true DK1556488T3 (da) | 2008-12-08 |
Family
ID=32185313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03758057T DK1556488T3 (da) | 2002-10-31 | 2003-10-24 | Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060100145A1 (da) |
| EP (1) | EP1556488B1 (da) |
| AT (1) | ATE405648T1 (da) |
| AU (1) | AU2003274076A1 (da) |
| DE (1) | DE50310383D1 (da) |
| DK (1) | DK1556488T3 (da) |
| WO (1) | WO2004039978A2 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1202064A1 (en) * | 2011-10-13 | 2015-09-18 | 托马斯．盖德克 | Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030096299A1 (en) * | 2001-07-09 | 2003-05-22 | Valerie Wittamer | Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
-
2003
- 2003-10-24 AU AU2003274076A patent/AU2003274076A1/en not_active Abandoned
- 2003-10-24 US US10/533,300 patent/US20060100145A1/en not_active Abandoned
- 2003-10-24 DK DK03758057T patent/DK1556488T3/da active
- 2003-10-24 AT AT03758057T patent/ATE405648T1/de not_active IP Right Cessation
- 2003-10-24 WO PCT/EP2003/011799 patent/WO2004039978A2/de not_active Ceased
- 2003-10-24 DE DE50310383T patent/DE50310383D1/de not_active Expired - Fee Related
- 2003-10-24 EP EP03758057A patent/EP1556488B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004039978A3 (de) | 2004-07-22 |
| AU2003274076A1 (en) | 2004-05-25 |
| EP1556488A2 (de) | 2005-07-27 |
| ATE405648T1 (de) | 2008-09-15 |
| WO2004039978A2 (de) | 2004-05-13 |
| DE50310383D1 (de) | 2008-10-02 |
| EP1556488B1 (de) | 2008-08-20 |
| US20060100145A1 (en) | 2006-05-11 |
| AU2003274076A8 (en) | 2004-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| BRPI0413728A (pt) | muteìnas de lipocalina da lágrima | |
| WO2006071778A3 (en) | Treatment of parkinson's disease and related disorders using postpartum derived cells | |
| FI20021145A0 (fi) | Laitteisto elintoimintojen mittaamiseksi | |
| DE50014411D1 (de) | Medizinisches instrument zur abtragung von gewebe, knochenzement oder dergleichen im menschlichen oder tierischen körper | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| WO2004031129A3 (en) | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection | |
| NO20062355L (no) | Sammensetninger for behandling av sykdom i munnhulen og ovre andedrettssystem | |
| BRPI0409359A (pt) | análogos quiméricos de somatostatina-dopamina | |
| NO20071238L (no) | Fremgangsmater for leging av skader ved human IL-18 administrering | |
| MXPA05003818A (es) | Perfilamiento de la expresion genica de muestras ffpe. | |
| WO2005072277A3 (en) | Amidated parathyroid hormone fragments and uses thereof | |
| WO2008029142A3 (en) | A bone plate for fixation to a patient's vertebrae | |
| DK1556488T3 (da) | Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme | |
| CY1112440T1 (el) | Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3 | |
| ITBO20030261A1 (it) | Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei. | |
| ATE506961T1 (de) | Ccn3 proteine zur behandlung und diagnose von nierenerkrankungen | |
| EA200600314A1 (ru) | Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях | |
| PL1612210T3 (pl) | Nowe analogi nitrobenzylotioinozyny | |
| Nerlich et al. | Paleopathological and radiological evidence for cerebral paralysis in an ancient Egyptian female mummy from a 13th dynasty tomb. | |
| RU2303413C2 (ru) | Способ формирования фронтального отдела верхней челюсти, верхней губы, преддверия полости рта и твердого неба | |
| Shrestha et al. | A Retrospective Study of 97 Patients with Zygomatic Bone Fractures. | |
| WO2003097690A3 (en) | Pth derivatives resistant to skin proteases | |
| ATE473295T1 (de) | Nukleotidträger zur diagnose und therapie oraler erkrankungen | |
| BRPI0407333A (pt) | Uso de antagonistas do receptor b2 de bradiquinina para o tratamento de osteoartrose |